- JP-listed companies
- Income statement
【JP:7079】Income statement
Market cap
¥6.4B
P/E ratio
8.5x
WDB Coco provides outsourcing services to help pharmaceutical companies with drug safety monitoring, regulatory document preparation, and clinical research support.
| 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 982 | 1,140 | 1,467 | 1,782 | 2,286 | 2,571 | 3,615 | 4,071 | 4,596 | 5,327 |
| Revenue growth (%) | - | |||||||||
| Cost of revenue | - | - | - | 1,187 | 1,414 | 1,667 | 2,176 | 2,481 | 2,655 | 3,250 |
| Gross profit | - | - | - | 594 | 872 | 903 | 1,439 | 1,589 | 1,941 | 2,077 |
| Gross margin (%) | - | - | - | |||||||
| Operating margin (%) | - | - | - | |||||||
| Operating expenses | - | - | - | 256 | 398 | 379 | 476 | 503 | 668 | 771 |
| Operating income | - | - | - | 338 | 473 | 525 | 963 | 1,086 | 1,273 | 1,306 |
| Income before tax | 212 | 229 | 297 | 338 | 461 | 527 | 963 | 1,088 | 1,273 | 1,310 |
| Pretax margin (%) | 21.6 | 20.1 | 20.2 | 19 | 20.2 | 20.5 | 26.6 | 26.7 | 27.7 | 24.6 |
| Provision for income taxes | - | - | - | 102 | 139 | 154 | 313 | 344 | 415 | 397 |
| Effective tax rate (%) | - | - | - | |||||||
| Net income | 137 | 161 | 198 | 237 | 307 | 373 | 648 | 744 | 858 | 913 |
| Net income margin (%) | ||||||||||
| Earnings per share | 682,675.81 | 806,354.22 | 99.12 | 118.33 | 147.59 | 163.11 | 273.94 | 311.24 | 356.9 | 379.61 |
| Diluted EPS | - | - | - | - | 140.93 | 156.04 | 269.64 | 309.31 | 356.47 | - |
| Dividend payout ratio (%) | - | - | - | - | - | |||||
| Dividend per share | - | - | - | - | 34 | 35 | 40 | 41 | 75 | 80 |
| EBITDA | - | - | - | |||||||
| EBITDA margin (%) | - | - | - |